San Diego-based Diversa Corp., which collects tiny organisms from exotic landscapes, is getting ready to collect royalty payments from the sale of three key enzymes.
Diversa said a licensing agreement signed with San Diego-based Invitrogen Corp., which develops and sells research tools, including enzymes to scientists, has paid off.
“The licensed enzymes are the first commercial products to result from an enzyme evaluation agreement between Invitrogen and Diversa signed last year,” Diversa reported.
